Wossmann W, Siemens H, Beck B, Jansen B, Wiedemann G, Wagner T
UNIV LUBECK,DEPT INTERNAL MED,D-23538 LUBECK,GERMANY.
Int J Oncol. 1996 Aug;9(2):305-12. doi: 10.3892/ijo.9.2.305.
Induction of HSP70 and thermotolerance may also decrease the cytotoxicity of cytostatic agents or their combination with hyperthermia in clinically used thermochemotherapy. HSP70 and thermotolerance were induced by hyperthermia (42 degrees C, 1 h) in two human tumor cell lines in vitro and in vivo. The influence of thermotolerance on the cytotoxicity of CDDP and the oxazaphosphorine compounds Mafo and Ifo and their combination with hyperthermia (42 degrees C or 43 degrees C, 1 h) were studied. The results show that neither thermotolerance nor HSP70 affects the tumor cell sensitivity to CDDP or oxazaphosphorine compounds. However, the additive effect of hyperthermia and CDDP was found to be attenuated in thermotolerant cells. The cytotoxicity of oxazaphosphorine compounds combined with hyperthermia was not altered after preheating, suggesting a different mechanism may be responsible for the drug-hyperthermia interaction of CDDP and oxazaphosphorine compounds. There were no differences between in vitro and in vivo results suggesting mechanisms at the cellular level being responsible for the influence of thermotolerance on drug- and drug-hyperthermia action.
在临床应用的热化疗中,热休克蛋白70(HSP70)的诱导和热耐受也可能降低细胞毒性药物或其与热疗联合使用时的细胞毒性。通过体外和体内42℃、1小时的热疗在两个人类肿瘤细胞系中诱导HSP70和热耐受。研究了热耐受对顺铂(CDDP)、恶唑磷类化合物马法兰(Mafo)和异环磷酰胺(Ifo)细胞毒性的影响,以及它们与42℃或43℃、1小时热疗联合使用时的影响。结果表明,热耐受和HSP70均不影响肿瘤细胞对CDDP或恶唑磷类化合物的敏感性。然而,在热耐受细胞中,热疗和CDDP的相加作用减弱。恶唑磷类化合物与热疗联合使用的细胞毒性在预热后未改变,这表明CDDP和恶唑磷类化合物的药物-热疗相互作用可能有不同机制。体外和体内结果之间没有差异,表明细胞水平的机制负责热耐受对药物及药物-热疗作用的影响。